During the past decade, Willis-Knighton Pain Management Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Willis-Knighton Pain Management Center" are "Chronic Pain" (2 trials), "Pain" (2 trials), "Breakthrough Pain" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Willis-Knighton Pain Management Center" in a lesser frequency.

Most popular intervention types in "Willis-Knighton Pain Management Center" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Fentanyl Buccal Tablets" (1 trials), "Fentanyl Buccal Tablets Compared With Immediate-Release Oxycodone" (1 trials) and "Sublingual sufentanil NanoTabs™ and placebo NanoTabs™" (1 trials). Other intervention names were less common.

The vast majority of trials in "Willis-Knighton Pain Management Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Willis-Knighton Pain Management Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Willis-Knighton Pain Management Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Willis-Knighton Pain Management Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".